Latent Mycobacterium tuberculosis infection

N Engl J Med. 2015 May 28;372(22):2127-35. doi: 10.1056/NEJMra1405427.
No abstract available

Publication types

  • Review

MeSH terms

  • Antitubercular Agents / administration & dosage*
  • Antitubercular Agents / adverse effects
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Humans
  • Isoniazid / administration & dosage*
  • Latent Tuberculosis* / diagnosis
  • Latent Tuberculosis* / drug therapy
  • Latent Tuberculosis* / epidemiology
  • Latent Tuberculosis* / etiology
  • Mycobacterium tuberculosis*
  • Practice Guidelines as Topic
  • Rifampin / administration & dosage
  • Rifampin / analogs & derivatives
  • Risk Factors

Substances

  • Antitubercular Agents
  • Isoniazid
  • Rifampin
  • rifapentine